K. McLendon

Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19

N. Rouphael, A. Piantadosi, Varun K. Phadke, 2022, Open forum infectious diseases.

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection

S. Stowell, J. Guarner, J. Waggoner, 2022, medRxiv.

Sensitivity of Rapid Antigen Tests Against SARS-CoV-2 Omicron and Delta Variants

E. Ortlund, H. Bowers, A. Greninger, 2023, medRxiv.

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers

S. Stowell, M. Dhodapkar, J. Guarner, 2022, Research square.

Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers

Joseph M. Johnson, S. Stowell, M. Dhodapkar, 2022, medRxiv.

SARS-CoV-2 reliably detected in frozen saliva samples stored up to one year

Adrianna L Westbrook, S. Gillespie, J. Roback, 2022, PloS one.

Where is Omicron? Comparison of SARS-CoV-2 RT-PCR and Antigen Test Sensitivity at Commonly Sampled Anatomic Sites Over the Course of Disease

Adrianna L Westbrook, J. Waggoner, A. Piantadosi, 2022, medRxiv.

The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs

Adrianna L Westbrook, N. Pollock, R. Parsons, 2023, medRxiv.

Sensitivity of rapid antigen tests against SARS-CoV-2 Omicron and Delta variants

E. Ortlund, Adrianna L Westbrook, H. Bowers, 2023, Journal of Clinical Microbiology.

Protocol for the creation and characterization of SARS-CoV-2 variant testing panels using remnant clinical samples for diagnostic assay testing

A. Piantadosi, J. Sullivan, K. McLendon, 2024, STAR protocols.

The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs.

Adrianna L Westbrook, N. Pollock, K. McLendon, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection

N. Schoof, J. Waggoner, A. Piantadosi, 2023, Open forum infectious diseases.